[EN] ARYLSULFONAMIDE CCR3 ANTAGONISTS<br/>[FR] ANTAGONISTES DU CCR3 DE TYPE ARYLSULFONAMIDE
申请人:AXIKIN PHARMACEUTICALS INC
公开号:WO2011116161A2
公开(公告)日:2011-09-22
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3 -mediated disorder, disease, or condition.